Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Mittalhenkle A"'
Autor:
Drachenberg, C.B. *, Torrealba, J.R., Nankivell, B.J., Rangel, E.B., Bajema, I.M., Kim, D.U., Arend, L., Bracamonte, E.R., Bromberg, J.S., Bruijn, J.A., Cantarovich, D., Chapman, J.R., Farris, A.B., Gaber, L., Goldberg, J.C., Haririan, A., Honsová, E., Iskandar, S.S., Klassen, D.K., Kraus, E., Lower, F., Odorico, J., Olson, J.L., Mittalhenkle, A., Munivenkatappa, R., Paraskevas, S., Papadimitriou, J.C., Randhawa, P., Reinholt, F.P., Renaudin, K., Revelo, P., Ruiz, P., Samaniego, M.D., Shapiro, R., Stratta, R.J., Sutherland, D.E.R., Troxell, M.L., Voska, L., Seshan, S.V., Racusen, L.C., Bartlett, S.T.
Publikováno v:
In American Journal of Transplantation September 2011 11(9):1792-1802
Autor:
Troxell, Megan L., Dunlap, Jennifer B., Mittalhenkle, Anuja, Ishag, Mona, Fan, Guang, Huang, James Z., Gatter, Ken, Byrd, Dan M., Webster, Devon, Houghton, Donald C.
Publikováno v:
In American Journal of Kidney Diseases 2008 52(6):1174-1179
Publikováno v:
Pathology - Research and Practice. 207:15-23
Glomerular fibrin thrombi may be an early indication of antibody-mediated rejection in renal allograft biopsies. However, fibrin thrombi have a broad differential; thus, we sought to evaluate the etiology and implications of glomerular fibrin thrombi
Autor:
Douglas J. Norman, Ali J. Olyaei, Anuja Mittalhenkle, M. Prikis, Stephen C. Rayhill, Megan L. Troxell
Publikováno v:
American Journal of Transplantation. 10:2717-2722
Pancreas transplantation is an effective treatment option for patients with complicated diabetes mellitus. Pancreas allograft recipients are followed with laboratory markers such as serum amylase, lipase and glucose levels. Hyperglycemia may indicate
Autor:
Ali J. Olyaei, Jagdeep S. Obhrai, Anuja Mittalhenkle, Eric Langewisch, Jordana Gaumond, Jennifer Kay Leach
Publikováno v:
Clinical Journal of the American Society of Nephrology. 5:1518-1529
Before transplantation, the general nephrologist is the primary resource for potential kidney transplantation recipients. After transplantation, the general nephrologist is increasingly managing transplant medications and complications. We provide ev
Autor:
David Bradley Koslin, Stephen C. Rayhill, Douglas J. Norman, Anuja Mittalhenkle, Megan L. Troxell
Publikováno v:
Transplantation. 90:75-84
Background Pancreas and kidney allograft function is routinely monitored with serum studies (amylase, lipase, and creatinine). Increased levels commonly prompt tissue biopsy, to diagnose cause of graft dysfunction. Historically, pancreas allografts w
Autor:
Miha Arnol, Douglas J. Norman, Jonathan C. Prather, Angelo M. de Mattos, Anuja Mittalhenkle, Jae S. Chung
Publikováno v:
Transplantation. 86:1844-1848
Cardiovascular events (CVE) are the leading cause of mortality in kidney transplant recipients. The adverse effects of long-term therapy with steroids on cardiovascular risk have motivated increasing interest in steroid withdrawal (SW). The objective
Long-Term Kidney Regraft Survival From Deceased Donors: Risk Factors and Outcomes in a Single Center
Publikováno v:
Transplantation. 86:1084-1089
Background Although survival of kidney regrafts is similar to that of primary grafts, risk factors associated with regraft survival have not been defined clearly. The aim of this study was to investigate risk factors for regraft outcome, including ch
Publikováno v:
American Journal of Kidney Diseases. 44:672-679
The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71e8516a52217dfe9b0f1fc60e3b1ee0
https://europepmc.org/articles/PMC4620991/
https://europepmc.org/articles/PMC4620991/